Additional file 1 of The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling

Marr, Alexander R.; Halpin, Madeline; Corbin, Dominique L.; Asemelash, Yerdanos; Sher, Steven; Gordon, Britten K.; Whipp, Ethan C.; Mitchell, Shaneice; Harrington, Bonnie K.; Orwick, Shelley; Benrashid, Samon; Goettl, Virginia M.; Yildiz, Vedat; Mitchell, Andrew D.; Cahn, Olivia; Mims, Alice S.; Larkin, Karilyn T. M.; Long, Meixao; Blachly, James; Woyach, Jennifer A.; Lapalombella, Rosa; Grieselhuber, Nicole R.

doi:10.6084/m9.figshare.25341172.v1

40164_2024_483_MOESM1_ESM.pptx (10.38 MB)

Additional file 1 of The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling

presentation

posted on 2024-03-05, 09:41 authored by Alexander R. Marr, Madeline Halpin, Dominique L. Corbin, Yerdanos Asemelash, Steven Sher, Britten K. Gordon, Ethan C. Whipp, Shaneice Mitchell, Bonnie K. Harrington, Shelley Orwick, Samon Benrashid, Virginia M. Goettl, Vedat Yildiz, Andrew D. Mitchell, Olivia Cahn, Alice S. Mims, Karilyn T. M. Larkin, Meixao Long, James Blachly, Jennifer A. Woyach, Rosa Lapalombella, Nicole R. Grieselhuber

Supplementary Material 1